Hot startup Theranos dials back lab tests at FDA's behest: a) To expand its market share b) To improve test accuracy c) Due to regulatory concerns d) To reduce costs

The FDA prompted Theranos, a startup company, to reduce its lab tests due to regulatory concerns. This action was not taken to expand market share, enhance test accuracy or decrease expenses, but because of concerns raised about the reliability of Theranos' tests. Option c is the answer.

Explanation:

The startup company Theranos was advised by the FDA to limit its lab tests, primarily due to regulatory concerns. Rather than a move to increase market share, improve test accuracy, or cut costs, this decision was mainly formulated in response to regulatory inquiries and scrutiny. The FDA, which is a government body responsible for protecting and promoting public health, raised certain concerns about the effectiveness and reliability of the tests that Theranos was providing to its customers. Hence, until those concerns were adequately addressed, Theranos decided to dial back its lab tests.

Learn more about Theranos and FDA here:

https://brainly.com/question/32115109

#SPJ11